Per month after the second session, a better percentage from the significant-dose groups no more fulfilled diagnostic criteria for PTSD, compared with the minimal-dose team.Correction: An before version of the Tale explained Amy Emerson was executive director and director of medical exploration for MAPS; that's incorrect."We've got to have a 2,000